The iconic pottery maker reports encouraging sales growth and a renewed focus on its craft heritage, aiming to return to profitability next year after a period of job cuts and industry-wide challenges.
While Stabilus SE's recent profit figures appeared subdued, a closer examination reveals underlying strength and potential for a rebound, as the market's positive reaction suggests.
Precious metals continue their sharp retreat from January's record highs, with silver leading the decline as market sentiment shifts following key U.S. policy signals.
In Thailand's crucial northeast, a profound political realignment is underway. Farmers, disillusioned by unmet promises and economic hardship, are abandoning decades of party loyalty to back individual candidates, testing the foundations of the Shinawatra family's political machine ahead of pivotal elections.
As the pet care market expands, investors weigh the focused approach of Chewy against Walmart's diversified scale. While Chewy offers pure exposure, Walmart's broader ecosystem and advertising growth present a compelling alternative.
Kuya Silver reports a record quarterly production haul from its Bethania silver mine alongside accelerated underground development, drawing investor focus. However, a premium valuation against a backdrop of ongoing losses presents a complex picture for the junior miner.
Lucky Strike Entertainment's stock has tumbled nearly 24% over the past year, raising critical questions about its true worth. We analyze whether the current price reflects underlying value or signals an overextended valuation.
Cardiac monitoring specialist iRhythm has finalized a significant corporate restructuring, creating a new parent company to serve as its publicly listed entity on Nasdaq. The move is seen as a strategic step to streamline governance and provide operational flexibility as the company expands its AI-driven health platform.
Shares of insulin pump maker Tandem Diabetes Care have plummeted over 80% in five years, trading near $20. A deep dive into valuation metrics suggests the stock may now be modestly undervalued, but significant risks and competitive pressures remain.
Shares of PROG Holdings (PRG) have rallied sharply in recent months, prompting investors to scrutinize whether the fintech company's current valuation reflects its underlying fundamentals or is simply riding a wave of market momentum.
Seagate Technology Holdings' stock surged following a strong fiscal Q2 report, fueled by robust demand from AI and data center markets. The company's revenue guidance and multi-year visibility for its advanced HAMR-based storage platform signal confidence in sustained growth, though execution risks remain.
Travere Therapeutics faces a securities fraud investigation by Robbins Geller Rudman & Dowd LLP, raising questions about the accuracy of its past disclosures. The probe casts a shadow over the company's critical transition, as it banks on its kidney drug FILSPARI to drive growth amid mounting legal and commercial pressures.
Shares of Advantest Corp. have surged nearly 200% in the past year, riding the AI and advanced chipmaking wave. As the stock trades near record highs, investors are grappling with a critical question: has the rally run too far, too fast?
Tripadvisor and Best Western's new AI-driven travel platform for the 2026 FIFA World Cup showcases the company's potential in high-stakes tourism. Yet, for investors, the real test remains translating innovation into sustained growth and market-beating returns.
Amid a patchy eurozone recovery, investors are scanning the market's fringes for potential. We spotlight three small-cap stocks from Norway and Sweden, each navigating unique challenges while showing flashes of promise for the discerning, risk-tolerant investor.
Despite a 25% drop in earnings per share, Coronation Fund Managers (JSE:CML) delivered a robust 57% total shareholder return over the past year, driven by revenue growth and strong market sentiment, outperforming the broader South African market.
Sanofi's experimental oral drug venglustat demonstrated significant neurological benefits for patients with Type 3 Gaucher disease in a late-stage trial, but failed to meet its primary endpoint in a separate study for Fabry disease, casting uncertainty on its regulatory path.
Despite a recent 9.4% share price decline, Bytes Technology Group (BYIT) showcases exceptional financial health with a 69% ROE, suggesting the current weakness may be a buying opportunity for patient investors.
Cross-chain protocol CrossCurve has been exploited for an estimated $3 million, with a critical smart contract flaw allowing unauthorized fund withdrawals across multiple blockchains. The incident renews scrutiny on bridge security and user protections in decentralized finance.
As diplomatic efforts to secure a ceasefire in Gaza show fragile progress, Israeli airstrikes have resulted in the deaths of at least 30 Palestinians overnight, with multiple children among the casualties, according to local health authorities.
